Exact Mass: 710.345465

Exact Mass Matches: 710.345465

Found 28 metabolites which its exact mass value is equals to given mass value 710.345465, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

nudicauline

[(1alpha,5xi,6beta,9xi,10xi,14alpha)-14-(Acetyloxy)-20-ethyl-7,8-dihydroxy-1,6,16-trimethoxyaconitan-4-yl]methyl 2-(3-methyl-2,5-dioxopyrrolidin-1-yl)benzoate

C38H50N2O11 (710.341443)

Origin: Plant; SubCategory_DNP: Terpenoid alkaloids, Diterpene alkaloid, Delphinium alkaloid

Strophanthin

K-Strophanthin-beta

C36H54O14 (710.3513384)

D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D013328 - Strophanthins D002317 - Cardiovascular Agents D004791 - Enzyme Inhibitors

Boivinide A

Corotoxigenin-3-O-beta-D-glucopyranosyl-(1->4)-beta-D-digitalopyranoside

C36H54O14 (710.3513384)

Atractyloside H

Atractyloside H

C32H54O17 (710.3360834)

Strophanthin

7,11-dihydroxy-5-[(4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-15-methyl-14-(5-oxo-2,5-dihydrofuran-3-yl)tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecane-2-carbaldehyde

C36H54O14 (710.3513384)

D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D013328 - Strophanthins D002317 - Cardiovascular Agents D004791 - Enzyme Inhibitors

Andersoline

[4-(acetyloxy)-11-ethyl-8,9-dihydroxy-6,16,18-trimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl]methyl 2-(3-methyl-2,5-dioxopyrrolidin-1-yl)benzoate

C38H50N2O11 (710.341443)

Geyerline

Geyerline

C38H50N2O11 (710.341443)

Gluco-lanadoxin

Gluco-lanadoxin

C36H54O14 (710.3513384)

sarmutogenin glucosyl-diginoside

sarmutogenin glucosyl-diginoside

C36H54O14 (710.3513384)

Delta16-8beta-hydroxydigitoxigenin beta-odorobioside

Delta16-8beta-hydroxydigitoxigenin beta-odorobioside

C36H54O14 (710.3513384)

C36H54O14

C36H54O14 (710.3513384)

(3S,6Z,9S,12S,18S,23aS)-18-(1-hydroxyethyl)-3-(hydroxymethyl)-6-[(1H-indol-3-yl)methylidene]-12-methyl-9-(2-methylpropyl)hexadecahydro-1H-pyrrolo[1,2-a] [1,4,7,10,13,16,19]heptaazacyclohenicosine-1,4,7,10,13,16,19-heptone|cyclo-(Pro1-Ser2-Delta-Trp3-Leu4-Ala5-Gly6-Thr7)|tunicyclin G

(3S,6Z,9S,12S,18S,23aS)-18-(1-hydroxyethyl)-3-(hydroxymethyl)-6-[(1H-indol-3-yl)methylidene]-12-methyl-9-(2-methylpropyl)hexadecahydro-1H-pyrrolo[1,2-a] [1,4,7,10,13,16,19]heptaazacyclohenicosine-1,4,7,10,13,16,19-heptone|cyclo-(Pro1-Ser2-Delta-Trp3-Leu4-Ala5-Gly6-Thr7)|tunicyclin G

C34H46N8O9 (710.3387586)

Erycorchosid|Eryperosid

Erycorchosid|Eryperosid

C36H54O14 (710.3513384)

3,4-dimethoxy pycnocomolide|3,4-Dimethoxy-Pycnocomolide|3,4-dimethoxypycnocomolide

3,4-dimethoxy pycnocomolide|3,4-Dimethoxy-Pycnocomolide|3,4-dimethoxypycnocomolide

C43H50O9 (710.345465)

3-beta-[(O-beta-D-glucopyranosyl-(1->3)-4,6-dideoxy-2-O-methyl-beta-D-gulopyranosyl)]-5beta,14beta-dihydroxy-19-oxocard-20(22)enolide

3-beta-[(O-beta-D-glucopyranosyl-(1->3)-4,6-dideoxy-2-O-methyl-beta-D-gulopyranosyl)]-5beta,14beta-dihydroxy-19-oxocard-20(22)enolide

C36H54O14 (710.3513384)

Nudicaulinea

Nudicaulinea

C38H50N2O11 (710.341443)

C36H54O14_Card-20(22)-enolide, 3-[(2,6-dideoxy-4-O-beta-D-glucopyranosyl-3-O-methyl-beta-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxo-, (3beta,5beta)

NCGC00384630-01_C36H54O14_Card-20(22)-enolide, 3-[(2,6-dideoxy-4-O-beta-D-glucopyranosyl-3-O-methyl-beta-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxo-, (3beta,5beta)-

C36H54O14 (710.3513384)

C36H54O14_Card-20(22)-enolide, 3-[(6-deoxy-4-O-hexopyranosyl-3-O-methylhexopyranosyl)oxy]-14-hydroxy-19-oxo

NCGC00384920-01_C36H54O14_Card-20(22)-enolide, 3-[(6-deoxy-4-O-hexopyranosyl-3-O-methylhexopyranosyl)oxy]-14-hydroxy-19-oxo-

C36H54O14 (710.3513384)

MELYR

Met-Glu-Leu-Tyr-Arg

C31H50N8O9S (710.3421290000001)

3-O(4-O-beta-D-glucopyranosyl-alpha-L-rhamnopyranosyl)-3beta,14beta,16beta-trihydroxy-5beta-bufa-20,22-dienolide

3-O(4-O-beta-D-glucopyranosyl-alpha-L-rhamnopyranosyl)-3beta,14beta,16beta-trihydroxy-5beta-bufa-20,22-dienolide

C36H54O14 (710.3513384)

Strophanthin K

K-Strophanthin-beta

C36H54O14 (710.3513384)

D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D013328 - Strophanthins

3beta-[(O-beta-D-Glucopyranosyl-(1->3)-4,6-dideoxy-2-O-methyl-beta-D-gulopyranosyl)]-5beta,14beta-dihydroxy-19-oxocard-20(22)enolide

3beta-[(O-beta-D-Glucopyranosyl-(1->3)-4,6-dideoxy-2-O-methyl-beta-D-gulopyranosyl)]-5beta,14beta-dihydroxy-19-oxocard-20(22)enolide

C36H54O14 (710.3513384)

A cardenolide glycoside that is strophanthidin attached to a 4,6-dideoxy-3-O-(beta-D-glucopyranosyl)-2-O-methyl-beta-D-xylo-hexopyranosyl residue at position 3 via a glycosidic linkage. Isolated from Crossosoma bigelovii, it exhibits cytotoxic activity.

[(1S,2S,4S,5R,6S,8R,9R,10R,13S,16S,18S)-6-acetyloxy-11-ethyl-8,9-dihydroxy-4,16,18-trimethoxy-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecan-13-yl]methyl 2-[(3S)-3-methyl-2,5-dioxopyrrolidin-1-yl]benzoate

[(1S,2S,4S,5R,6S,8R,9R,10R,13S,16S,18S)-6-acetyloxy-11-ethyl-8,9-dihydroxy-4,16,18-trimethoxy-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecan-13-yl]methyl 2-[(3S)-3-methyl-2,5-dioxopyrrolidin-1-yl]benzoate

C38H50N2O11 (710.341443)

HBMP 30:7;O

HBMP 30:7;O

C36H55O12P (710.343096)

PG 22:5/8:3;O2

PG 22:5/8:3;O2

C36H55O12P (710.343096)

PG 22:6/8:2;O2

PG 22:6/8:2;O2

C36H55O12P (710.343096)

PG 30:8;O2

PG 30:8;O2

C36H55O12P (710.343096)

3a-hydroxy-7-[(3-hydroxy-4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-11a-methyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthrene-9a-carbaldehyde

3a-hydroxy-7-[(3-hydroxy-4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-11a-methyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthrene-9a-carbaldehyde

C36H54O14 (710.3513384)